Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Hongwei Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5575-6396; OpenAlex author ID A5101425416. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 2 papers · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 14

  1. Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer. Co-author DOI 10.1038/s41388-026-03979-3↗
  2. Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database. Co-author DOI 10.1155/2021/5573628↗
  3. Pseudostellaria heterophylla Extract Polysaccharide H-1-2 Suppresses Pancreatic Cancer by Inhibiting Hypoxia-Induced AG2. Co-author DOI 10.1016/j.omto.2020.03.007↗
  4. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.14813↗
  5. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance. Co-author DOI 10.3389/fonc.2020.617190↗
  6. Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. Co-author DOI 10.3389/fimmu.2019.02819↗
  7. LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448. Co-author DOI 10.1002/jcp.26072↗
  8. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. First author DOI 10.1038/s41419-017-0196-z↗
  9. Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic can… Co-author DOI 10.1111/cas.13347↗
  10. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382. First author DOI 10.1159/000479990↗
  11. Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2017.5526↗
  12. Mitochondrial tRNALeu(CUN) A12307G variant may not be associated pancreatic cancer. Last author DOI 10.4238/gmr.15027906↗
  13. Solanine induces mitochondria-mediated apoptosis in human pancreatic cancer cells. Co-author DOI 10.1155/2014/805926↗
  14. Antitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivo. Co-author DOI 10.1371/journal.pone.0087868↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mengtao Zhou · 7 shared papers, 2014–2020 · strength 0.54
  2. Hezhi Fang · 3 shared papers, 2018–2026 · strength 0.44
  3. Bicheng Chen · 4 shared papers, 2014–2018 · strength 0.28
  4. Xiaojun Ren · 1 shared paper, 2026 · strength 0.27
  5. Weidong Yu · 1 shared paper, 2026 · strength 0.27
  6. Tao Xia · 1 shared paper, 2026 · strength 0.27
  7. Wei Cui · 1 shared paper, 2026 · strength 0.27
  8. Keqing Shi · 2 shared papers, 2019–2020 · strength 0.23
  9. Shengjie Dai · 2 shared papers, 2019–2021 · strength 0.23
  10. Dinglai Yu · 2 shared papers, 2017–2021 · strength 0.20
  11. Yukai Xiang · 2 shared papers, 2017–2021 · strength 0.20
  12. Chaohao Huang · 2 shared papers, 2017–2021 · strength 0.20
  13. Zongjing Chen · 2 shared papers, 2017–2018 · strength 0.18
  14. Liang Zhao · 2 shared papers, 2017–2018 · strength 0.18
  15. Jianxin Lyu · 2 shared papers, 2018–2020 · strength 0.17
  16. Bi Lin · 1 shared paper, 2021 · strength 0.13
  17. Shenmeng Gao · 1 shared paper, 2020 · strength 0.11
  18. Jiajia Li · 1 shared paper, 2020 · strength 0.11
  19. Mengtao Zhou · 1 shared paper, 2018 · strength 0.10
  20. Xianglai Ye · 1 shared paper, 2020 · strength 0.10
  21. Xujun He · 1 shared paper, 2020 · strength 0.10
  22. Xiujuan Wei · 1 shared paper, 2020 · strength 0.10
  23. Guoquan Cao · 1 shared paper, 2017 · strength 0.08
  24. Chongqing Lv · 2 shared papers, 2014 · strength 0.08
  25. Kehua Pan · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.